Format

Send to

Choose Destination
Int Urol Nephrol. 2008;40(2):539-41.

De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.

Author information

1
Servicio de Nefrología, Hospital General Universitario Valle de Hebron, Barcelona 08035, Spain. jltovar@vhebron.net

Abstract

This paper describes the case of a patient with HCV, without previous evidence of nephropathy, who following two well-tolerated cycles of treatment with interferon alone developed nephrotic syndrome after a third attempt with ribavirin associated with peginterferon alfa 2b. The patient exhibited a total remission when the antiviral treatment was discontinued.

PMID:
17987400
DOI:
10.1007/s11255-007-9241-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center